Pharmaceutical solutions are a huge piece of patient idea all through the world. For bosses to sufficiently think about their patients, consistent security must be watched and revealed from beginning testing to basic use. This is the universe of pharmacovigilance. The World Health Organization depicts pharmacovigilance (PV) as "the science and exercises identifying with the exposure, appraisal, perception and avoidance of antagonistic impacts or some other medication related issue.” Pharmacovigilance starts with clinical essentials that give information on the central focuses and hazards of a medication. The motivation behind pharmacovigilance in clinical examination is to pick whether the great conditions outperform the dangers; in the event that they do, quiet creators make sense of how to get guaranteeing to broadcast the new solution. The information can be published in our peer reviewed journal with impact factors and are calculated using citations not only from research articles but also review articles (which tend to receive more citations), editorials, letters, meeting abstracts, short communications, and case reports. The inclusion of these publications provides the opportunity for editors and publishers to manipulate the ratio used to calculate the impact factor and try to increase their number rapidly. Impact factor plays a major role for the particular journal. Journal with higher impact factor is considered to be more important than other ones.